publicações selecionadas
-
artigo académico
- Exosomes modified with anti-MEK1 siRNA lead to an effective silencing of triple negative breast cancer cells. Biomaterials Advances. 2023
-
artigo de conferência
-
documento
- Exosome-mediated MEK1 silencing is a promising approach against triple negative breast cancer regression 2022
- Exossomas modificados para o desenvolvimento de novas terapias para cancro de mama triplo negativo 2021
- Engineered exosome-mediated delivery of RNAi therapeutics towards triple negative breast cancer therapy 2021
- Peptide-mediated targeted delivery system towards triple negative breast cancer treatment 2020